Takara Bio (FRA:TF2) E10: €0.25 (As of Mar. 2026)


FRA:TF2 Takara Bio Inc FRA:TF2
71 GF Score
Price €5.95
GF Value €4.46
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio E10?

Takara Bio FRA:TF2 71 E10 is €0.25 as of Mar. 2026. GuruFocus rates FRA:TF2 with a GF Score™ of 71/100 and a GF Value™ of €4.46 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Takara Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Takara Bio's average E10 Growth Rate was -15.40% per year. During the past 3 years, the average E10 Growth Rate was -3.50% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Takara Bio was 49.80% per year. The lowest was -3.50% per year. And the median was 30.70% per year.

As of today (2026-06-26), Takara Bio's current stock price is €5.95. Takara Bio's E10 for the quarter that ended in Mar. 2026 was €0.25. Takara Bio's Shiller PE Ratio of today is 23.80.

During the past 13 years, the highest Shiller PE Ratio of Takara Bio was 279.01. The lowest was 13.68. And the median was 85.07.


Takara Bio  (FRA:TF2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Takara Bio's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5.95/0.25
=23.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Takara Bio was 279.01. The lowest was 13.68. And the median was 85.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Takara Bio E10 Related Terms


Takara Bio E10 Historical Data

* Premium members only.

The historical data trend for Takara Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takara Bio E10 Chart

Takara Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.35 0.31 0.32 0.25

Takara Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.30 0.27 0.24 0.25

FRA:TF2 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Takara Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takara Bio Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Takara Bio's Shiller PE Ratio falls into.


FRA:TF2
71GF Score
Takara Bio Inc FRA:TF2
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takara Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takara Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.001/112.7000*112.7000
=0.001

Current CPI (Mar. 2026) = 112.7000.

Takara Bio Quarterly Data

per share eps CPI Adj_EPS
201606 0.020 98.100 0.023
201609 0.028 98.000 0.032
201612 0.061 98.400 0.070
201703 -0.014 98.100 -0.016
201706 0.002 98.500 0.002
201709 0.018 98.800 0.021
201712 0.048 99.400 0.054
201803 0.080 99.200 0.091
201806 0.067 99.200 0.076
201809 0.044 99.900 0.050
201812 0.024 99.700 0.027
201903 0.104 99.700 0.118
201906 0.108 99.800 0.122
201909 0.034 100.100 0.038
201912 0.043 100.500 0.048
202003 0.078 100.300 0.088
202006 0.028 99.900 0.032
202009 0.125 99.900 0.141
202012 0.227 99.300 0.258
202103 0.245 99.900 0.276
202106 0.377 99.500 0.427
202109 0.255 100.100 0.287
202112 0.281 100.100 0.316
202203 0.349 101.100 0.389
202206 0.229 101.800 0.254
202209 0.271 103.100 0.296
202212 0.352 104.100 0.381
202303 0.082 104.400 0.089
202306 0.017 105.200 0.018
202309 0.040 106.200 0.042
202312 -0.049 106.800 -0.052
202403 0.068 107.200 0.071
202406 -0.051 108.200 -0.053
202409 0.082 108.900 0.085
202412 -0.098 110.700 -0.100
202503 0.125 111.100 0.127
202506 -0.075 111.700 -0.076
202509 -0.258 112.000 -0.260
202512 -0.123 113.000 -0.123
202603 0.001 112.700 0.001

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.25 mean?
Takara Bio (FRA:TF2) has a E10 of €0.25 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Takara Bio and its competitors.
Is Takara Bio's E10 too high?
Takara Bio's current E10 is €0.25. Overall, Takara Bio has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takara Bio's E10 compare to VRTX and REGN?
Takara Bio's E10 of €0.25 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Takara Bio and its competitors. Takara Bio's current E10 is €0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takara Bio stock overvalued right now?
Based on GuruFocus' analysis, Takara Bio (FRA:TF2) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.46, compared to a current price of €5.95 — trading 33.4% above its estimated fair value. The current E10 is €0.25. Takara Bio's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Takara Bio (FRA:TF2), the current E10 is €0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takara Bio (FRA:TF2) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of €5.95 is trading 33.4% above its estimated GF Value™ of €4.46. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for FRA:TF2:

  • E10: €0.25
  • GF Value™: €4.46 vs. price of €5.95 (33.4% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the FRA:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Takara Bio Business Description

Other Exchanges 4974:Japan
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
71GF Score

Get the complete analysis for FRA:TF2

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.95
Price
€4.46
GF Value